Global Neurology Academy

Assessing Sex-Based Treatment Responses to Gepants In Migraine Management
Assessing Sex-Based Treatment Responses to Gepants In Migraine Management
Global Neurology Academy
Assessing Sex-Based Treatment Responses to Gepants In Migraine Management
Improving Spinal Muscular Atrophy Outcomes Through Early Intervention
Improving Spinal Muscular Atrophy Outcomes Through Early Intervention
NeuroFrontiers
Improving Spinal Muscular Atrophy Outcomes Through Early Intervention
- Charles Turck, PharmD, BCPS, BCCCP
- Leslie Hayes, MD
American Headache Society Updates on Diagnosing and Treating Migraine
American Headache Society Updates on Diagnosing and Treating Migraine
NeuroFrontiers
American Headache Society Updates on Diagnosing and Treating Migraine
- Charles Turck, PharmD, BCPS, BCCCP
- Jessica Ailani, MD, FAHS, FAAN, FANA
Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
Global Neurology Academy
Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
- Andrew G. Lee, MD
- Ashley Baker, MSN, PMHNP
Spinal Muscular Atrophy Care: Optimizing Therapeutic Decision Making
Spinal Muscular Atrophy Care: Optimizing Therapeutic Decision Making
NeuroFrontiers
Spinal Muscular Atrophy Care: Optimizing Therapeutic Decision Making
- Charles Turck, PharmD, BCPS, BCCCP
- John Brandsema, MD
Identifying CIDP: A Guide to Risk Profiles and Clinical Presentation
Identifying CIDP: A Guide to Risk Profiles and Clinical Presentation
Global Neurology Academy
Identifying CIDP: A Guide to Risk Profiles and Clinical Presentation
- Nicolas Dubuisson, MD
- Ryan Quigley
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
NeuroFrontiers
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
- Kaitlin Batley, MD
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
Global Neurology Academy
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
- Chafic Karam, MD
- Ryan Quigley

Medical News

Medical News
Potential Prenatal Markers Associated with Autism: A New Era of Early Detection
07/17/2025
Read more
Medical News
Alzheimer’s Diagnostic Innovations: Blood Tests and Vaccine Trials
07/17/2025
Read more
Medical News
Confronting Stigma and Circadian Misalignment in Depression Care
07/17/2025
Read more
Medical News
Revolutionizing Osteoarthritis Care with Tai Chi and Yoga: Synchronizing Sleep and Pain Relief
07/17/2025
Read more

See more news

CME/CE

Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
CME/CE Meeting
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
July 30, 2025
Toronto
Learn more
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
MinuteCE®
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
1.25 program credits
- James R. Bateman, MD, MPH
- Charles P. Vega, MD
- B. Joy Snider, MD, PhD
1.25 program credits
MinuteCE®
Clinical Conundrums in ARIA: Navigating Case Scenarios in Your Own Practice Setting
1.25 credits 11 episodes
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- B. Joy Snider, MD, PhD
- Charles P. Vega, MD
1.25 credits 11 episodes
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
MinuteCE®
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Jerome A. Barakos, MD
1.25 program credits

Clinical Practice

Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
NeuroFrontiers
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
- John Golden
- Michael Greenberg, MD
Transforming Clinician Wellness: EEG Headphones Helping with Burnout
Transforming Clinician Wellness: EEG Headphones Helping with Burnout
NeuroFrontiers
Transforming Clinician Wellness: EEG Headphones Helping with Burnout
- John Golden
- Michael Greenberg, MD
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
NeuroFrontiers
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
Global Neurology Academy
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
- Danielle Minetti
- Ryan Quigley

Programs

Managing Migraine: Inadequate Responses and Treatment Transitions
Managing Migraine: Inadequate Responses and Treatment Transitions
NeuroFrontiers
Managing Migraine: Inadequate Responses and Treatment Transitions
- Charles Turck, PharmD, BCPS, BCCCP
- Vincent Martin, MD, FACP, FAHS
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
NeuroFrontiers
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
- Christopher A. Scheiner, MD, PhD
Managing MS in Older Adults: Top 5 Clinical Considerations
Managing MS in Older Adults: Top 5 Clinical Considerations
NeuroFrontiers
Managing MS in Older Adults: Top 5 Clinical Considerations
- Yinan Zhang, MD
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
NeuroFrontiers
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
- John A. Morren, MD, FAAN, FAANEM